Cart
sales@molnova.com
STX-478
STX-478
Catalog No. M37154
STX-478 is an orally active and selective PI3Kα inhibitor that penetrates the blood-brain barrier and has anticancer activity to inhibit tumor growth.STX-478 is indicated for the study of breast cancer and other cancers.
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 206 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 302 | In Stock |
|
| 25MG | 541 | In Stock |
|
| 50MG | 797 | In Stock |
|
| 100MG | 1190 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSTX-478
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. JR David St Jean, et al. Urea derivatives which can be used to treat cancer. Patent WO2022265993A1.
molnova catalog
related products
-
SN-32976
SN-32976 is a novel, potent and selective class I PI3K and mTOR inhibitor.
-
NVP-BKM120
NVP-BKM120 (BKM-120, Buparlisib)?is a potent, selective, orally bioavailable inhibitor of class I PI3K isoforms.
-
PI-103
A potent, dual class I PI3K/mTOR inhibitor with IC50 of 2/3/3/15/ for p110α/β/δ/γ, respectively.
